[
  {
    "published_date": "2025-05-30",
    "title": "면역관용요법(Immune Tolerance Induction) 요양급여 대상여부(2사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F05%2F30%2F1%2FRV202505301680622&fnm=4.%2520%25EB%25A9%25B4%25EC%2597%25AD%25EA%25B4%2580%25EC%259A%25A9%25EC%259A%2594%25EB%25B2%2595%2528Immune%2520Tolerance%2520Induction%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%25282%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-05-30_공개사례_면역관용요법(ImmuneToleranceInductio_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-05-30",
    "title": "Burosumab 주사제(품명: 크리스비타주) 요양급여 대상여부(2사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F05%2F30%2F1%2FRV202505301680637&fnm=5.%2520Burosumab%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25ED%2581%25AC%25EB%25A6%25AC%25EC%258A%25A4%25EB%25B9%2584%25ED%2583%2580%25EC%25A3%25BC%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%25282%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-05-30",
    "title": "병변 위치 및 시술일에 따른 ESD(내시경적 점막하 박리절제술) 수가 산정방법(4사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-05-30",
    "title": "혈관내초음파(IVUS) 결과 심근 허혈 유발 병변으로 판단하여 시행한 경피적 관상동맥 중재술 인정여부(1사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-05-30",
    "title": "중간부 우관상동맥 만성완전폐쇄(mRCA CTO) 병변에 다수 사용한 치료재료 인정여부(1사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-05-30",
    "title": "영구적심박동기 삽입 후 익일 심실전극을 제거하고 새로운 전극을 삽입한 경우 관련 수기료 인정여부(1사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-05-30",
    "title": "운동부하검사 결과 유의미한 혈압 강하 없이 시행한 심율동 전환 제세동기 거치술(ICD) 인정여부(1사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-05-30",
    "title": "영구적심박동기(PPM) 시술료 인정여부(1사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-05-30",
    "title": "미세협착(Minimal stenosis)에 시행한 관상동맥내 압력측정술(FFR) 및 치료재료 인정여부(1사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-05-23",
    "title": "[자동차보험][25-2-A-1] 진료내역 참조, 교통사고환자의 근골격·연부 초음파검사 인정여부(2사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-04-29",
    "title": "심실 보조장치 치료술(VAD) 요양급여 대상여부(14사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F04%2F29%2F1%2FRV202504291527568&fnm=1.%2520%25EC%258B%25AC%25EC%258B%25A4%2520%25EB%25B3%25B4%25EC%25A1%25B0%25EC%259E%25A5%25EC%25B9%2598%2520%25EC%25B9%2598%25EB%25A3%258C%25EC%2588%25A0%2528VAD%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%252814%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-04-29_공개사례_심실보조장치치료술(VAD)요양급여대상여부(14사례)_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-04-29",
    "title": "Eculizumab 주사제(품명: 솔리리스주 등) 및 Ravulizumab(품명: 울토미리스주 등) 요양급여 대상여부(15사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F04%2F29%2F1%2FRV202504291527583&fnm=2.%2520Eculizumab%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%2586%2594%25EB%25A6%25AC%25EB%25A6%25AC%25EC%258A%25A4%25EC%25A3%25BC%2520%25EB%2593%25B1%2529%2520%25EB%25B0%258F%2520Ravulizumab%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%259A%25B8%25ED%2586%25A0%25EB%25AF%25B8%25EB%25A6%25AC%25EC%258A%25A4%25EC%25A3%25BC%2520%25EB%2593%25B1%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%252815%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-04-29_공개사례_Eculizumab주사제(품명솔리리스주등)및Ravuli_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-04-29",
    "title": "조혈모세포이식 분과위원회(70사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F04%2F29%2F1%2FRV202504291527594&fnm=3.%2520%25EC%25A1%25B0%25ED%2598%2588%25EB%25AA%25A8%25EC%2584%25B8%25ED%258F%25AC%25EC%259D%25B4%25EC%258B%259D%2520%25EB%25B6%2584%25EA%25B3%25BC%25EC%259C%2584%25EC%259B%2590%25ED%259A%258C%252870%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-04-29_공개사례_조혈모세포이식분과위원회(70사례)_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-04-29",
    "title": "Nusinersen sodium 주사제(품명: 스핀라자주) 및 Risdiplam 경구제(품명: 에브리스디건조시럽), Onasemnogene abeparvovec 주사제(품명: 졸겐스마주) 요양급여 대상 여부(42사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F04%2F29%2F1%2FRV202504291527608&fnm=4.%2520Nusinersen%2520sodium%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%258A%25A4%25ED%2595%2580%25EB%259D%25BC%25EC%259E%2590%25EC%25A3%25BC%2529%2520%25EB%25B0%258F%2520Risdiplam%2520%25EA%25B2%25BD%25EA%25B5%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%2597%2590%25EB%25B8%258C%25EB%25A6%25AC%25EC%258A%25A4%25EB%2594%2594%25EA%25B1%25B4%25EC%25A1%25B0%25EC%258B%259C%25EB%259F%25BD%2529%252C%2520Onasemnogene%2520abeparvovec%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%25A1%25B8%25EA%25B2%2590%25EC%258A%25A4%25EB%25A7%2588%25EC%25A3%25BC%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%2520%25EC%2597%25AC%25EB%25B6%2580%252842%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-04-29_공개사례_Nusinersensodium주사제(품명스핀라자주)및R_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-04-29",
    "title": "부정맥 수술과 동시에 시행한 클립을 이용한 좌심방이 폐쇄술 요양급여 인정여부(3사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-04-29",
    "title": "자203-2 대동맥근부수술 수가 산정에 대하여(2사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-03-31",
    "title": "Eculizumab 주사제(품명: 솔리리스주 등) 및 Ravulizumab(품명: 울토미리스주 등) 요양급여 대상여부(3사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F03%2F31%2F1%2FRV202503311393957&fnm=Eculizumab%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%2586%2594%25EB%25A6%25AC%25EB%25A6%25AC%25EC%258A%25A4%25EC%25A3%25BC%2520%25EB%2593%25B1%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%25283%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-03-31_공개사례_Eculizumab주사제(품명솔리리스주등)및Ravuli_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-03-31",
    "title": "Nusinersen sodium 주사제(품명: 스핀라자주) 및 Risdiplam 경구제(품명: 에브리스디건조시럽) 요양급여 대상 여부(48사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F03%2F31%2F1%2FRV202503311393993&fnm=Nusinersen%2520sodium%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%258A%25A4%25ED%2595%2580%25EB%259D%25BC%25EC%259E%2590%25EC%25A3%25BC%2529%2520%25EB%25B0%258F%2520Risdiplam%2520%25EA%25B2%25BD%25EA%25B5%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%2597%2590%25EB%25B8%258C%25EB%25A6%25AC%25EC%258A%25A4%25EB%2594%2594%25EA%25B1%25B4%25EC%25A1%25B0%25EC%258B%259C%25EB%259F%25BD%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%2520%25EC%2597%25AC%25EB%25B6%2580%252848%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-03-31_공개사례_Nusinersensodium주사제(품명스핀라자주)및R_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-03-31",
    "title": "Onasemnogene abeparvovec 주사제(품명:졸겐스마주) 성과평가(9사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F05%2F30%2F1%2FRV202505301681070&fnm=Onasemnogene%2520abeparvovec%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%25A1%25B8%25EA%25B2%2590%25EC%258A%25A4%25EB%25A7%2588%25EC%25A3%25BC%2529%2520%25EC%2584%25B1%25EA%25B3%25BC%25ED%258F%2589%25EA%25B0%2580%25289%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-03-31_공개사례_Onasemnogeneabeparvovec주사제(품명졸_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-03-31",
    "title": "수술내역 비교, 뇌종양·뇌혈관질환에 대한 개두술마취 가산료 인정여부(11사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-03-31",
    "title": "심실 보조장치 치료술(VAD) 요양급여 대상여부(16사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F03%2F31%2F1%2FRV202503311394118&fnm=%25EC%258B%25AC%25EC%258B%25A4%2520%25EB%25B3%25B4%25EC%25A1%25B0%25EC%259E%25A5%25EC%25B9%2598%2520%25EC%25B9%2598%25EB%25A3%258C%25EC%2588%25A0%2528VAD%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%252816%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-03-31_공개사례_심실보조장치치료술(VAD)요양급여대상여부(16사례)_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-02-27",
    "title": "심실 보조장치 치료술(VAD) 요양급여 대상여부(13사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F02%2F27%2F1%2FRV202502271254897&fnm=1.%2520%25EC%258B%25AC%25EC%258B%25A4%2520%25EB%25B3%25B4%25EC%25A1%25B0%25EC%259E%25A5%25EC%25B9%2598%2520%25EC%25B9%2598%25EB%25A3%258C%25EC%2588%25A0%2528VAD%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%252813%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-02-27_공개사례_심실보조장치치료술(VAD)요양급여대상여부(13사례)_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-02-27",
    "title": "요실금 수술과 동시 시행한 질벽봉합술(자408) 인정여부(17사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-02-27",
    "title": "「L1부위의 골절, 폐쇄성」등 상병에 시행한 ‘자47-1가 경피적 척추후굴풍선복원술［방사선료포함］-제1부위‘ 인정여부(1사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-02-27",
    "title": "「신경뿌리병증을 동반한 요추 및 기타 추간판장애」등 상병에 시행한 ‘자49가 관혈적 추간판제거술 ［척추후궁절제술포함］-요추‘  인정여부(1사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-02-27",
    "title": "「척추전방전위증, 요추부」등 상병에 시행한 ‘자46 척추고정술［기기,기구사용고정포함］’ 인정여부(2사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-02-27",
    "title": "Nusinersen sodium 주사제(품명: 스핀라자주) 및 Risdiplam 경구제(품명: 에브리스디건조시럽), Onasemnogene abeparvovec 주사제(품명: 졸겐스마주) 요양급여 대상 여부(32사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F02%2F27%2F1%2FRV202502271254904&fnm=6.%2520Nusinersen%2520sodium%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%258A%25A4%25ED%2595%2580%25EB%259D%25BC%25EC%259E%2590%25EC%25A3%25BC%2529%2520%25EB%25B0%258F%2520Risdiplam%2520%25EA%25B2%25BD%25EA%25B5%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%2597%2590%25EB%25B8%258C%25EB%25A6%25AC%25EC%258A%25A4%25EB%2594%2594%25EA%25B1%25B4%25EC%25A1%25B0%25EC%258B%259C%25EB%259F%25BD%2529%252C%2520Onasemnogene%2520abeparvovec%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%25A1%25B8%25EA%25B2%2590%25EC%258A%25A4%25EB%25A7%2588%25EC%25A3%25BC%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%2520%25EC%2597%25AC%25EB%25B6%2580%252832%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-02-27_공개사례_Nusinersensodium주사제(품명스핀라자주)및R_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-02-27",
    "title": "Voretigene neparvovec 주사제(품명: 럭스터나주) 요양급여 대상 여부(2사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F02%2F27%2F1%2FRV202502271254906&fnm=7.%2520Voretigene%2520neparvovec%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EB%259F%25AD%25EC%258A%25A4%25ED%2584%25B0%25EB%2582%2598%25EC%25A3%25BC%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%2520%25EC%2597%25AC%25EB%25B6%2580%25282%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-02-27_공개사례_Voretigeneneparvovec주사제(품명럭스터나_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-02-27",
    "title": "면역관용요법 요양급여 대상여부(1사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F02%2F27%2F1%2FRV202502271254909&fnm=8.%2520%25EB%25A9%25B4%25EC%2597%25AD%25EA%25B4%2580%25EC%259A%25A9%25EC%259A%2594%25EB%25B2%2595%2528Immune%2520Tolerance%2520Induction%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%25281%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-02-27_공개사례_면역관용요법요양급여대상여부(1사례)_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-02-27",
    "title": "Burosumab 주사제(품명: 크리스비타주) 요양급여 대상 여부(2사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F02%2F27%2F1%2FRV202502271254911&fnm=9.%2520Burosumab%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25ED%2581%25AC%25EB%25A6%25AC%25EC%258A%25A4%25EB%25B9%2584%25ED%2583%2580%25EC%25A3%25BC%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%2520%25EC%2597%25AC%25EB%25B6%2580%25282%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-02-27_공개사례_Burosumab주사제(품명크리스비타주)요양급여대상여부_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-02-27",
    "title": "Eculizumab 주사제(품명: 솔리리스주 등) 요양급여 대상여부(3사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F02%2F27%2F1%2FRV202502271254913&fnm=10.%2520Eculizumab%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%2586%2594%25EB%25A6%25AC%25EB%25A6%25AC%25EC%258A%25A4%25EC%25A3%25BC%2520%25EB%2593%25B1%2529%2520%25EB%25B0%258F%2520Ravulizumab%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%259A%25B8%25ED%2586%25A0%25EB%25AF%25B8%25EB%25A6%25AC%25EC%258A%25A4%25EC%25A3%25BC%2520%25EB%2593%25B1%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%25283%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-02-27_공개사례_Eculizumab주사제(품명솔리리스주등)요양급여대상여_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-02-27",
    "title": "심율동 전환 제세동기 거치술(ICD) 및 심장재동기화치료(CRT) 요양급여 대상여부(1사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F02%2F27%2F1%2FRV202502271254915&fnm=11.%2520%25EC%258B%25AC%25EC%259C%25A8%25EB%258F%2599%2520%25EC%25A0%2584%25ED%2599%2598%2520%25EC%25A0%259C%25EC%2584%25B8%25EB%258F%2599%25EA%25B8%25B0%2520%25EA%25B1%25B0%25EC%25B9%2598%25EC%2588%25A0%2528ICD%2529%2520%25EB%25B0%258F%2520%25EC%258B%25AC%25EC%259E%25A5%25EC%259E%25AC%25EB%258F%2599%25EA%25B8%25B0%25ED%2599%2594%25EC%25B9%2598%25EB%25A3%258C%2528CRT%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%25281%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-02-27_공개사례_심율동전환제세동기거치술(ICD)및심장재동기화치료(CRT_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-02-27",
    "title": "조혈모세포이식 요양급여(필수)/선별급여 대상 승인여부 (56사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F02%2F27%2F1%2FRV202502271254917&fnm=12.%2520%25EC%25A1%25B0%25ED%2598%2588%25EB%25AA%25A8%25EC%2584%25B8%25ED%258F%25AC%25EC%259D%25B4%25EC%258B%259D%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2528%25ED%2595%2584%25EC%2588%2598%2529%2520%25EC%2584%25A0%25EB%25B3%2584%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%2520%25EC%258A%25B9%25EC%259D%25B8%25EC%2597%25AC%25EB%25B6%2580%252856%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-02-27_공개사례_조혈모세포이식요양급여(필수)선별급여대상승인여부(56사례_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-02-27",
    "title": "흉부 삼차원 CT 요양급여 인정여부(2사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-02-27",
    "title": "미만성거대B세포림프종(DLBCL)에서, 완전반응(CR) 상태에서 시행한 고용량 메토트렉세이트(HD-MTX)와 자가조혈모세포이식을 2차 치료로 판단하고 투여한 tisagenlecleucel(품명: 킴리아주) 요양급여 인정여부(1사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-02-27",
    "title": "소아의 골수형성이상증후군에 투여한 azacitidine(품명: 비다자주) 요양급여 인정여부(1사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-01-31",
    "title": "심실 보조장치 치료술(VAD) 요양급여 대상여부(10사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F01%2F31%2F1%2FRV202501311121295&fnm=1.%2520%25EC%258B%25AC%25EC%258B%25A4%2520%25EB%25B3%25B4%25EC%25A1%25B0%25EC%259E%25A5%25EC%25B9%2598%2520%25EC%25B9%2598%25EB%25A3%258C%25EC%2588%25A0%2528VAD%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%252810%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-01-31_공개사례_심실보조장치치료술(VAD)요양급여대상여부(10사례)_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-01-31",
    "title": "Eculizumab 주사제(품명: 솔리리스주 등) 요양급여 대상여부(5사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F01%2F31%2F1%2FRV202501311121341&fnm=2.%2520Eculizumab%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%2586%2594%25EB%25A6%25AC%25EB%25A6%25AC%25EC%258A%25A4%25EC%25A3%25BC%2520%25EB%2593%25B1%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%25285%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-01-31_공개사례_Eculizumab주사제(품명솔리리스주등)요양급여대상여_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-01-31",
    "title": "진료내역 등 참조, 상·하악골 양성종양(낭종포함)절제술 인정여부에 대하여(11사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-01-31",
    "title": "Burosumab 주사제(품명: 크리스비타주) 요양급여 대상 여부(2사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F01%2F31%2F1%2FRV202501311121372&fnm=4.%2520Burosumab%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25ED%2581%25AC%25EB%25A6%25AC%25EC%258A%25A4%25EB%25B9%2584%25ED%2583%2580%25EC%25A3%25BC%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%2520%25EC%2597%25AC%25EB%25B6%2580%25282%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-01-31_공개사례_Burosumab주사제(품명크리스비타주)요양급여대상여부_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-01-31",
    "title": "Nusinersen sodium 주사제(품명: 스핀라자주) 요양급여 대상 여부(35사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F01%2F31%2F1%2FRV202501311121381&fnm=5.%2520Nusinersen%2520sodium%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%258A%25A4%25ED%2595%2580%25EB%259D%25BC%25EC%259E%2590%25EC%25A3%25BC%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%2520%25EC%2597%25AC%25EB%25B6%2580%252835%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-01-31_공개사례_Nusinersensodium주사제(품명스핀라자주)요양_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-01-31",
    "title": "심율동 전환 제세동기 거치술(ICD) 및 심장재동기화치료(CRT) 요양급여 대상여부(5사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F01%2F31%2F1%2FRV202501311121385&fnm=6.%2520%25EC%258B%25AC%25EC%259C%25A8%25EB%258F%2599%2520%25EC%25A0%2584%25ED%2599%2598%2520%25EC%25A0%259C%25EC%2584%25B8%25EB%258F%2599%25EA%25B8%25B0%2520%25EA%25B1%25B0%25EC%25B9%2598%25EC%2588%25A0%2528ICD%2529%2520%25EB%25B0%258F%2520%25EC%258B%25AC%25EC%259E%25A5%25EC%259E%25AC%25EB%258F%2599%25EA%25B8%25B0%25ED%2599%2594%25EC%25B9%2598%25EB%25A3%258C%2528CRT%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%25285%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-01-31_공개사례_심율동전환제세동기거치술(ICD)및심장재동기화치료(CRT_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-01-31",
    "title": "면역관용요법(Immune Tolerance Induction) 요양급여 대상여부(2사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F01%2F31%2F1%2FRV202501311121402&fnm=7.%2520%25EB%25A9%25B4%25EC%2597%25AD%25EA%25B4%2580%25EC%259A%25A9%25EC%259A%2594%25EB%25B2%2595%2528Immune%2520Tolerance%2520Induction%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%25282%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-01-31_공개사례_면역관용요법(ImmuneToleranceInductio_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2025-01-31",
    "title": "조혈모세포이식 요양급여(필수)_선별급여 대상 승인여부(49사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F01%2F31%2F1%2FRV202501311121421&fnm=8.%2520%25EC%25A1%25B0%25ED%2598%2588%25EB%25AA%25A8%25EC%2584%25B8%25ED%258F%25AC%25EC%259D%25B4%25EC%258B%259D%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2528%25ED%2595%2584%25EC%2588%2598%2529_%25EC%2584%25A0%25EB%25B3%2584%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%2520%25EC%258A%25B9%25EC%259D%25B8%25EC%2597%25AC%25EB%25B6%2580%252849%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2025-01-31_공개사례_조혈모세포이식요양급여(필수)_선별급여대상승인여부(49사_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-30",
    "title": "[자동차보험][24-11-B-11] 진료내역 및 청구경향 참조, 한방 다종시술 인정여부(4사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-24",
    "title": "Onasemnogene abeparvovec 주사제(품명:졸겐스마주) 성과평가",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2024%2F12%2F31%2F1%2FRV202412310991543&fnm=1.%2520Onasemnogene%2520abeparvovec%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%25A1%25B8%25EA%25B2%2590%25EC%258A%25A4%25EB%25A7%2588%25EC%25A3%25BC%2529%2520%25EC%2584%25B1%25EA%25B3%25BC%25ED%258F%2589%25EA%25B0%2580.pdf"
    ],
    "saved_files": [
      "2024-12-24_공개사례_Onasemnogeneabeparvovec주사제(품명졸_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-24",
    "title": "Eculizumab 주사제(품명:  솔리리스주 등) 요양급여 대상여부",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2024%2F12%2F31%2F1%2FRV202412310991548&fnm=2.%2520Eculizumab%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%2520%25EC%2586%2594%25EB%25A6%25AC%25EB%25A6%25AC%25EC%258A%25A4%25EC%25A3%25BC%2520%25EB%2593%25B1%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580.pdf"
    ],
    "saved_files": [
      "2024-12-24_공개사례_Eculizumab주사제(품명솔리리스주등)요양급여대상여_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-24",
    "title": "심실 보조장치 치료술(VAD) 요양급여 대상여부(19사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2024%2F12%2F31%2F1%2FRV202412310991554&fnm=3.%2520%25EC%258B%25AC%25EC%258B%25A4%2520%25EB%25B3%25B4%25EC%25A1%25B0%25EC%259E%25A5%25EC%25B9%2598%2520%25EC%25B9%2598%25EB%25A3%258C%25EC%2588%25A0%2528VAD%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%252819%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2024-12-24_공개사례_심실보조장치치료술(VAD)요양급여대상여부(19사례)_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-24",
    "title": "Nusinersen sodium 주사제(품명:  스핀라자주) 및 Risdiplam 경구제(품명:  에브리스디건조시럽) 요양급여 대상 여부",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2025%2F01%2F15%2F1%2FRV202501151065298&fnm=4.%2520Nusinersen%2520sodium%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%2520%25EC%258A%25A4%25ED%2595%2580%25EB%259D%25BC%25EC%259E%2590%25EC%25A3%25BC%2529%2520%25EB%25B0%258F%2520Risdiplam%2520%25EA%25B2%25BD%25EA%25B5%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%2520%25EC%2597%2590%25EB%25B8%258C%25EB%25A6%25AC%25EC%258A%25A4%25EB%2594%2594%25EA%25B1%25B4%25EC%25A1%25B0%25EC%258B%259C%25EB%259F%25BD%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%2520%25EC%2597%25AC%25EB%25B6%2580.hwp"
    ],
    "saved_files": [
      "2024-12-24_공개사례_Nusinersensodium주사제(품명스핀라자주)및R_1.hwp"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-24",
    "title": "심율동 전환 제세동기 거치술(ICD) 및 심장재동기화치료(CRT) 요양급여 대상여부(4사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2024%2F12%2F31%2F1%2FRV202412310991617&fnm=5.%2520%25EC%258B%25AC%25EC%259C%25A8%25EB%258F%2599%2520%25EC%25A0%2584%25ED%2599%2598%2520%25EC%25A0%259C%25EC%2584%25B8%25EB%258F%2599%25EA%25B8%25B0%2520%25EA%25B1%25B0%25EC%25B9%2598%25EC%2588%25A0%2528ICD%2529%2520%25EB%25B0%258F%2520%25EC%258B%25AC%25EC%259E%25A5%25EC%259E%25AC%25EB%258F%2599%25EA%25B8%25B0%25ED%2599%2594%25EC%25B9%2598%25EB%25A3%258C%2528CRT%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%25284%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2024-12-24_공개사례_심율동전환제세동기거치술(ICD)및심장재동기화치료(CRT_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-24",
    "title": "Burosumab 주사제(품명  크리스비타주) 요양급여 대상 여부",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2024%2F12%2F31%2F1%2FRV202412310991622&fnm=6.%2520Burosumab%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%2520%25ED%2581%25AC%25EB%25A6%25AC%25EC%258A%25A4%25EB%25B9%2584%25ED%2583%2580%25EC%25A3%25BC%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%2520%25EC%2597%25AC%25EB%25B6%2580.pdf"
    ],
    "saved_files": [
      "2024-12-24_공개사례_Burosumab주사제(품명크리스비타주)요양급여대상여부_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-24",
    "title": "조혈모세포이식 요양급여(필수) 선별급여 대상 승인여부(72사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2024%2F12%2F31%2F1%2FRV202412310991630&fnm=7.%2520%25EC%25A1%25B0%25ED%2598%2588%25EB%25AA%25A8%25EC%2584%25B8%25ED%258F%25AC%25EC%259D%25B4%25EC%258B%259D%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2528%25ED%2595%2584%25EC%2588%2598%2529%2520%25EC%2584%25A0%25EB%25B3%2584%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%2520%25EC%258A%25B9%25EC%259D%25B8%25EC%2597%25AC%25EB%25B6%2580%252872%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2024-12-24_공개사례_조혈모세포이식요양급여(필수)선별급여대상승인여부(72사례_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-24",
    "title": "누014 프로칼시토닌 나. 정밀면역검사(정량) 요양급여 인정여부(5사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-24",
    "title": "중심골(요추) 일부 부위의 골밀도 검사결과를 기준으로 청구한 denosumab 주사제(품명: 프롤리아프리필드시린지) 요양급여 인정여부(2사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-24",
    "title": "근골격계 상병에 통증조절을 위해 동일기관 반복 입원한 사례 입원료 인정여부(12사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-24",
    "title": "관절조영 인정여부(23사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-24",
    "title": "흉곽출구증후군(Thoracic Outlet Syndrome)에 실시한 수술적 치료의 수가산정방법(3사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-24",
    "title": "인공관절 삽입물 주위 골절 발생 시 재치환술과 동시 시행한 ‘자60가 사지골절정복술’ 인정여부(5사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-24",
    "title": "골전이암 등 근골격계 악성 종양 수술 시 ‘자28-1 악성 골종양의 광범위 절제술’인정여부 및 수가산정방법(3사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-02",
    "title": "Burosumab 주사제(품명: 크리스비타주) 요양급여 대상 여부",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2024%2F12%2F02%2F1%2FRV202412020869233&fnm=1.%2520Burosumab%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25ED%2581%25AC%25EB%25A6%25AC%25EC%258A%25A4%25EB%25B9%2584%25ED%2583%2580%25EC%25A3%25BC%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580.pdf"
    ],
    "saved_files": [
      "2024-12-02_공개사례_Burosumab주사제(품명크리스비타주)요양급여대상여부_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-02",
    "title": "Eculizumab 주사제(품명: 솔리리스주 등) 및 Ravulizumab(품명: 울토미리스주 등) 요양급여 대상여부",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2024%2F12%2F02%2F1%2FRV202412020869243&fnm=2.%2520Eculizumab%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%2586%2594%25EB%25A6%25AC%25EB%25A6%25AC%25EC%258A%25A4%25EC%25A3%25BC%2520%25EB%2593%25B1%2529%2520%25EB%25B0%258F%2520Ravulizumab%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%259A%25B8%25ED%2586%25A0%25EB%25AF%25B8%25EB%25A6%25AC%25EC%258A%25A4%25EC%25A3%25BC%2520%25EB%2593%25B1%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580.pdf"
    ],
    "saved_files": [
      "2024-12-02_공개사례_Eculizumab주사제(품명솔리리스주등)및Ravuli_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-02",
    "title": "심실 보조장치 치료술(VAD) 요양급여 대상여부",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2024%2F12%2F02%2F1%2FRV202412020869249&fnm=3.%2520%25EC%258B%25AC%25EC%258B%25A4%2520%25EB%25B3%25B4%25EC%25A1%25B0%25EC%259E%25A5%25EC%25B9%2598%2520%25EC%25B9%2598%25EB%25A3%258C%25EC%2588%25A0%2528VAD%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580.pdf"
    ],
    "saved_files": [
      "2024-12-02_공개사례_심실보조장치치료술(VAD)요양급여대상여부_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-02",
    "title": "Nusinersen sodium 주사제(품명: 스핀라자주) 및 Risdiplam 경구제(품명: 에브리스디건조시럽), Onasemnogene abeparvovec 주사제(품명: 졸겐스마주) 요양급여 대상 여부",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2024%2F12%2F02%2F1%2FRV202412020869291&fnm=4.%2520Nusinersen%2520sodium%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%258A%25A4%25ED%2595%2580%25EB%259D%25BC%25EC%259E%2590%25EC%25A3%25BC%2529%2520%25EB%25B0%258F%2520Risdiplam%2520%25EA%25B2%25BD%25EA%25B5%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%2597%2590%25EB%25B8%258C%25EB%25A6%25AC%25EC%258A%25A4%25EB%2594%2594%25EA%25B1%25B4%25EC%25A1%25B0%25EC%258B%259C%25EB%259F%25BD%2529%252C%2520Onasemnogene%2520abeparvovec%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%25A1%25B8%25EA%25B2%2590%25EC%258A%25A4%25EB%25A7%2588%25EC%25A3%25BC%2529%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580.pdf"
    ],
    "saved_files": [
      "2024-12-02_공개사례_Nusinersensodium주사제(품명스핀라자주)및R_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-02",
    "title": "후두경검사와 동시에 산정한 마14 후두내주입 인정여부",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-02",
    "title": "유방암 재발병변 없이 BRCA 유전자 돌연변이 양성으로 시행한 위험감소 유방전절제술 인정여부",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-02",
    "title": "유방암 진단 없이 BRCA 유전자 돌연변이 양성으로 시행한 위험감소 유방전절제술 인정여부",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-02",
    "title": "난소암 환자에서 유방 악성종양병변 없이 BRCA 유전자 돌연변이 양성으로 시행한 위험감소 유방전절제술 인정여부",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-02",
    "title": "Voretigene neparvovec 주사제(품명: 럭스터나주) 요양급여 대상 여부",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2024%2F12%2F02%2F1%2FRV202412020869378&fnm=9.%2520Voretigene%2520neparvovec%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EB%259F%25AD%25EC%258A%25A4%25ED%2584%25B0%25EB%2582%2598%25EC%25A3%25BC%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580.pdf"
    ],
    "saved_files": [
      "2024-12-02_공개사례_Voretigeneneparvovec주사제(품명럭스터나_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-02",
    "title": "조혈모세포이식 요양급여(필수)/선별급여 대상 승인여부",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2024%2F12%2F02%2F1%2FRV202412020869387&fnm=10.%2520%25EC%25A1%25B0%25ED%2598%2588%25EB%25AA%25A8%25EC%2584%25B8%25ED%258F%25AC%25EC%259D%25B4%25EC%258B%259D%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2528%25ED%2595%2584%25EC%2588%2598%2529%2520%25EC%2584%25A0%25EB%25B3%2584%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%2520%25EC%258A%25B9%25EC%259D%25B8%25EC%2597%25AC%25EB%25B6%2580.pdf"
    ],
    "saved_files": [
      "2024-12-02_공개사례_조혈모세포이식요양급여(필수)선별급여대상승인여부_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-02",
    "title": "심율동 전환 제세동기 거치술(ICD) 및 심장재동기화치료(CRT) 요양급여 대상여부",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2024%2F12%2F02%2F1%2FRV202412020869409&fnm=11.%2520%25EC%258B%25AC%25EC%259C%25A8%25EB%258F%2599%2520%25EC%25A0%2584%25ED%2599%2598%2520%25EC%25A0%259C%25EC%2584%25B8%25EB%258F%2599%25EA%25B8%25B0%2520%25EA%25B1%25B0%25EC%25B9%2598%25EC%2588%25A0%2528ICD%2529%2520%25EB%25B0%258F%2520%25EC%258B%25AC%25EC%259E%25A5%25EC%259E%25AC%25EB%258F%2599%25EA%25B8%25B0%25ED%2599%2594%25EC%25B9%2598%25EB%25A3%258C%2528CRT%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580.pdf"
    ],
    "saved_files": [
      "2024-12-02_공개사례_심율동전환제세동기거치술(ICD)및심장재동기화치료(CRT_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-02",
    "title": "바25아 척수신경총, 신경근 및 신경절차단술-척수신경 후지 요양급여 인정여부",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-02",
    "title": "암상병에 골스캔 시 청구한 ‘다319가 골스캔-전신 [정량분석]’ 인정여부",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-12-02",
    "title": "관절질환 상병에 골스캔 시 청구한 ‘다319가 골스캔-전신 [정량분석]’ 인정여부",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-10-31",
    "title": "Eculizumab 주사제(품명: 솔리리스주 등) 요양급여 대상여부(2사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2024%2F10%2F31%2F1%2FRV202410310736151&fnm=1.%2520Eculizumab%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%2586%2594%25EB%25A6%25AC%25EB%25A6%25AC%25EC%258A%25A4%25EC%25A3%25BC%2520%25EB%2593%25B1%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%25282%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2024-10-31_공개사례_Eculizumab주사제(품명솔리리스주등)요양급여대상여_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-10-31",
    "title": "Nusinersen sodium 주사제(품명: 스핀라자주) 요양급여 대상여부 및 Risdiplam 경구제(품명: 에브리스디건조시럽) 요양급여 대상여부(36사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2024%2F10%2F31%2F1%2FRV202410310736159&fnm=2.%2520Nusinersen%2520sodium%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%258A%25A4%25ED%2595%2580%25EB%259D%25BC%25EC%259E%2590%25EC%25A3%25BC%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%2520%25EB%25B0%258F%2520Risdiplam%2520%25EA%25B2%25BD%25EA%25B5%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EC%2597%2590%25EB%25B8%258C%25EB%25A6%25AC%25EC%258A%25A4%25EB%2594%2594%25EA%25B1%25B4%25EC%25A1%25B0%25EC%258B%259C%25EB%259F%25BD%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%252836%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2024-10-31_공개사례_Nusinersensodium주사제(품명스핀라자주)요양_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-10-31",
    "title": "심실 보조장치 치료술(VAD) 요양급여 대상여부(9사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2024%2F10%2F31%2F1%2FRV202410310736166&fnm=3.%2520%25EC%258B%25AC%25EC%258B%25A4%2520%25EB%25B3%25B4%25EC%25A1%25B0%25EC%259E%25A5%25EC%25B9%2598%2520%25EC%25B9%2598%25EB%25A3%258C%25EC%2588%25A0%2528VAD%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%25289%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2024-10-31_공개사례_심실보조장치치료술(VAD)요양급여대상여부(9사례)_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-10-31",
    "title": "Voretigene neparvovec 주사제(품명:럭스터나주) 성과평가(4사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2024%2F10%2F31%2F1%2FRV202410310736169&fnm=4.%2520Voretigene%2520neparvovec%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EB%259F%25AD%25EC%258A%25A4%25ED%2584%25B0%25EB%2582%2598%25EC%25A3%25BC%2529%2520%25EC%2584%25B1%25EA%25B3%25BC%25ED%258F%2589%25EA%25B0%2580%25284%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2024-10-31_공개사례_Voretigeneneparvovec주사제(품명럭스터나_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-10-31",
    "title": "Voretigene neparvovec 주사제(품명: 럭스터나주) 요양급여 대상여부(1사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2024%2F10%2F31%2F1%2FRV202410310736175&fnm=5.%2520Voretigene%2520neparvovec%2520%25EC%25A3%25BC%25EC%2582%25AC%25EC%25A0%259C%2528%25ED%2592%2588%25EB%25AA%2585%2520%25EB%259F%25AD%25EC%258A%25A4%25ED%2584%25B0%25EB%2582%2598%25EC%25A3%25BC%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%2520%25EC%2597%25AC%25EB%25B6%2580%25281%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2024-10-31_공개사례_Voretigeneneparvovec주사제(품명럭스터나_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-10-31",
    "title": "면역관용요법(Immune Tolerance Induction) 요양급여 대상여부(2사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2024%2F10%2F31%2F1%2FRV202410310736192&fnm=6.%2520%25EB%25A9%25B4%25EC%2597%25AD%25EA%25B4%2580%25EC%259A%25A9%25EC%259A%2594%25EB%25B2%2595%2528Immune%2520Tolerance%2520Induction%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%25282%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2024-10-31_공개사례_면역관용요법(ImmuneToleranceInductio_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-10-31",
    "title": "조혈모세포이식 요양급여(필수)/선별급여 대상여부(79사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2024%2F10%2F31%2F1%2FRV202410310736201&fnm=7.%2520%25EC%25A1%25B0%25ED%2598%2588%25EB%25AA%25A8%25EC%2584%25B8%25ED%258F%25AC%25EC%259D%25B4%25EC%258B%259D%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2528%25ED%2595%2584%25EC%2588%2598%2529_%25EC%2584%25A0%25EB%25B3%2584%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%252879%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2024-10-31_공개사례_조혈모세포이식요양급여(필수)선별급여대상여부(79사례)_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-10-31",
    "title": "심율동 전환 제세동기 거치술(ICD) 및 심장재동기화치료(CRT) 요양급여 대상여부(7사례)",
    "content": "",
    "file_urls": [
      "https://www.hira.or.kr/download.do?src=%2Fshare%2Fintranet%2Fsimsabank%2Fpaystd%2F2024%2F10%2F31%2F1%2FRV202410310736211&fnm=8.%2520%25EC%258B%25AC%25EC%259C%25A8%25EB%258F%2599%2520%25EC%25A0%2584%25ED%2599%2598%2520%25EC%25A0%259C%25EC%2584%25B8%25EB%258F%2599%25EA%25B8%25B0%2520%25EA%25B1%25B0%25EC%25B9%2598%25EC%2588%25A0%2528ICD%2529%2520%25EB%25B0%258F%2520%25EC%258B%25AC%25EC%259E%25A5%25EC%259E%25AC%25EB%258F%2599%25EA%25B8%25B0%25ED%2599%2594%25EC%25B9%2598%25EB%25A3%258C%2528CRT%2529%2520%25EC%259A%2594%25EC%2596%2591%25EA%25B8%2589%25EC%2597%25AC%2520%25EB%258C%2580%25EC%2583%2581%25EC%2597%25AC%25EB%25B6%2580%25287%25EC%2582%25AC%25EB%25A1%2580%2529.pdf"
    ],
    "saved_files": [
      "2024-10-31_공개사례_심율동전환제세동기거치술(ICD)및심장재동기화치료(CRT_1.pdf"
    ],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-10-31",
    "title": "갑상선암 수술 후 유미흉 진단 하에 투여한 Octreotide 주사제(품명: 옥트스타틴주) 인정여부(2사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-10-31",
    "title": "갑상선수질암의 재발판정을 위해 촬영한 F-18 FDG-PET 인정여부(1사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-10-31",
    "title": "갑상선암수술시 비회귀성 후두신경에 시행된 후두신경 감시술 인정여부(1사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-10-31",
    "title": "미주신경 신경초종(Schwannoma) 수술에 시행된 후두신경 감시술 인정여부(1사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-10-31",
    "title": "진료내역 참조, ‘자656다 만성폐쇄성병변에 대한 경피적 관상동맥스텐트삽입술’인정여부(1사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-10-31",
    "title": "경피적 관상동맥확장술 시 사용된 GUIDE EXTENSION CATHETER 인정여부(1사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-10-31",
    "title": "검사결과 참조, 신장이식 전 다회 시행한 ‘마102-다 치료적성분채집술-혈장’ 요양급여 인정여부(1사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  },
  {
    "published_date": "2024-10-31",
    "title": "이식신의 재발성 국소성 분절성 사구체신염(FSGS)에 다회 시행한 ‘마102-다 치료적성분채집술-혈장’ 요양급여 인정여부(1사례)",
    "content": "",
    "file_urls": [],
    "saved_files": [],
    "category": "공개사례",
    "relevant": ""
  }
]